Literature DB >> 994225

Detection and estimation of azomethane in expired air of 1,2-dimethylhydrazine-treated rats.

E S Fiala, C Kulakis, G Bobotas, J H Weisburger.   

Abstract

Azomethane (AM) gas was identified as a major metabolite of 1,2-dimethylhydrazine (1,2-DMH) in the expired air of F344 rats. The compound was characterized by high-pressure liquid chromatography, gas chromatography, and mass spectrometry, in comparison to a synthetic standard. At a dose of 21 mg 1,2-DMH/kg sc, approximately 14 and 11% of the dose were exhaled as AM and CO2, respectively, in 24 hours. At 200 mg 1,2-DMH/kg, 23 and 4% of the dose appeared as AM and CO2, respectively, in the respired air within the same period. Most AM was seen in the first 6 hours, but the CO2 evolution was more progressive, especially after the higher dose of 1,2-DMH.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 994225     DOI: 10.1093/jnci/56.6.1271

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  4 in total

Review 1.  Metabolism and activation of chemical carcinogens.

Authors:  E K Weisburger
Journal:  Mol Cell Biochem       Date:  1980-09-15       Impact factor: 3.396

Review 2.  Biochemical and molecular aspects of 1,2-dimethylhydrazine (DMH)-induced colon carcinogenesis: a review.

Authors:  Karthikkumar Venkatachalam; Ramachandran Vinayagam; Mariadoss Arokia Vijaya Anand; Nurulfiza Mat Isa; Rajasekar Ponnaiyan
Journal:  Toxicol Res (Camb)       Date:  2020-03-30       Impact factor: 3.524

3.  Metabolism of methylazoxymethanol acetate in the F344 rat and strain-2 guinea pig and its inhibition by pyrazole and disulfiram.

Authors:  E S Fiala; C Stathopoulos
Journal:  J Cancer Res Clin Oncol       Date:  1984       Impact factor: 4.553

4.  Differential effects of 4-iodopyrazole and 3-methylpyrazole on the metabolic activation of methylazoxymethanol to a DNA methylating species by rat liver and rat colon mucosa in vivo.

Authors:  E S Fiala; O S Sohn; C Puz; R Czerniak
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.